# The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease

> **NCT05217459** · NA · COMPLETED · sponsor: **Sinomed Neurovita Technology Inc.** · enrollment: 128 (actual)

## Conditions studied

- Intracranial Arterial Diseases
- Stent Restenosis
- Percutaneous Transluminal Angioplasty

## Interventions

- **DEVICE:** Self-expanding intracranial drug stent system

## Key facts

- **NCT ID:** NCT05217459
- **Lead sponsor:** Sinomed Neurovita Technology Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-04
- **Primary completion:** 2023-08-17
- **Final completion:** 2024-03-29
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2025-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05217459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05217459, "The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05217459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*